Grm2tm1(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Grm2tm1(KOMP)Wtsi |
| Name: |
glutamate receptor, metabotropic 2; targeted mutation 1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4363695 |
| Gene: |
Grm2 Location: Chr9:106521733-106533308 bp, - strand Genetic Position: Chr9, 57.98 cM
|
| IMPC: |
Grm2 gene page |
|
| Mutant Cell Lines: |
EPD0322_1_A02, EPD0322_1_B01, EPD0322_1_B04, EPD0322_1_C02, EPD0322_1_C03, EPD0322_1_D01, EPD0322_1_D03, EPD0322_1_E01, EPD0322_1_E03, EPD0322_1_F01, EPD0322_1_F02, EPD0322_1_G03, EPD0322_1_H02, EPD0322_1_H03, EPD0322_1_H04 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8A1.N3 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Pgk_P
|
| |
|
Mutation details: The insertion of the L1L2_Pgk_P cassette created a deletion of size 4162 starting at position 106524302 and ending at position 106528464 of Chromosome 9 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the PGK promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Grm2 Mutation: |
47 strains or lines available
|
|
| Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
| All: |
2 reference(s) |
|